FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new compounds of general formula 1:
wherein Q, X1, X2, Y, Z, R1, R2, R3, R3', R4, R4', R5, R6, R6' have the values specified in the description.
EFFECT: compounds are the IAP inhibitors which can be used as therapeutic agents for malignant diseases.
13 cl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
IAP INHIBITORS | 2006 |
|
RU2451025C2 |
IAP INHIBITORS | 2008 |
|
RU2491276C2 |
IAP INHIBITORS | 2005 |
|
RU2401840C2 |
ANTIVIRAL COMPOUNDS AND THEIR APPLICATION | 2010 |
|
RU2552533C2 |
ANTIRETROVIRAL COMPOUNDS AND USE THEREOF | 2010 |
|
RU2571662C2 |
BIS-QUARTERNARY CINCHONA ALKALOID SALTS AS ASYMMETRIC PHASE TRANSFER CATALYSTS | 2013 |
|
RU2667909C2 |
COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS | 2012 |
|
RU2606128C2 |
1,2,4-TRIAZINE-6-ONE DERIVATIVES, INHIBITING HIV | 2005 |
|
RU2401833C2 |
ENPP1 INHIBITORS AND METHODS OF MODULATING THE IMMUNE RESPONSE | 2018 |
|
RU2800798C2 |
NEW SULPHONAMIDE DERIVATIVES WITH SELECTIVE NOX INHIBITORY ACTIVITY | 2019 |
|
RU2809030C2 |
Authors
Dates
2012-11-10—Published
2007-12-14—Filed